What can RJ Health help you with?

What can RJ Health help you with?

Our Resources:

White Papers

Improving Claim Submission Accuracy Starts with Provider Engagement through Greater Transparency: A Case Study on NDC Mandates

Optimization of Specialty Drug Cost Under the Medical Benefit Part 01

Optimization of Specialty Drug Cost Under the Medical Benefit Part 02

Insights into the U.S. Biosimilar Marketplace

Fraud, Waste, and Abuse Issues and Avoidance Specific to Medical Drug Claims

Medical Drug Claim Edits to Optimize Reimbursement

Addressing Drug Wastage: A $3 Billion Challenge

Webinars

Quarterly Drug Coding, Reimbursement, and Pipeline Update Webinar – Q3 2019

Precision Medicine for Health Plans

Pricing Medical Drug Claims – 18 Minute On-Demand Webinar

Where is my NDC? – 17 Minute On-Demand Webinar

Creating Pre-Payment Controls for Medically Covered Drug Costs through Automation

Introduction to Leveraging Data to Prevent and Recover Fraud, Waste and Abuse in Medical Drug Claims

Utilizing NDCs for Medical Benefit Drugs – A Payor’s Perspective

Addressing Escalating Medical Benefit Drug Pricing

Optimization of Specialty Drug Costs Under the Medical Benefit

Shedding Light on Medically Covered Specialty Drug Pricing Methods

Demystifying the HCPCS Creation Process and its Relationship with Drugs Coming to Market

Vaccine Coding Challenges – 13 Minute On-Demand Webinar

Solving for Incorrectly Mapped NDC to HCPCS/CPT® Codes and Improperly Reported NDC Units

Specialty Drug Alerts

Our current collection of specialty drug pipeline reviews available to Drug Alerts subscribers includes:

Luspatercept

PDUFA: December 4, 2019
Last Updated: October 21, 2019

DOWNLOAD NOW



Nintedinab (Ofev®)

Original FDA Approval: October 15, 2019
Last Updated: October 21, 2019

DOWNLOAD NOW



Brolucizumab-dbll (Beovu®)

Original FDA Approval: October 7, 2019
Last Updated: October 7, 2019

DOWNLOAD NOW



Afamelanotide acetate (Scenesse®)

Original FDA Approval: October 8, 2019
Last Updated: October 14, 2019

DOWNLOAD NOW



Brolucizumab

Original FDA Approval: October 7, 2019
Last Updated: October 7, 2019

DOWNLOAD NOW



Ravulizumab-cwvz (Ultomiris™)

Original FDA Approval: December 21, 2018 Last Updated: August 27, 2019

DOWNLOAD NOW



Teriparatide

Original FDA Approval: November 26, 2002
Last Updated: August 15, 2019

DOWNLOAD NOW



Riluzole

Original FDA Approval: December 21, 1995
Last Updated: July 20, 2019

DOWNLOAD NOW



Avatrombopag (Doptelet®)

Original FDA Approval: May 21, 2019
Last Updated: June 26, 2019

DOWNLOAD NOW



Tafamidis meglumine (Vyndaqel®)

Original FDA Approval: May 3, 2014
Last Updated: June 11, 2019

DOWNLOAD NOW



Ruxolitinib phosphate (Jakafi®)

Original FDA Approval: November 16, 2011
Last Updated: May 24, 2019

DOWNLOAD NOW



Ado-trastuzumab emtansine (Kadcyla®)

Original FDA Approval: February 22, 2013
Last Updated: May 9, 2019

DOWNLOAD NOW



Romosozumab-aqqg (Evenity™)

Original FDA Approval: April 9, 2019
Last Updated: April 9, 2019

DOWNLOAD NOW



Tipiracil hydrochloride + Trifluridine (Lonsurf®)

Original FDA Approval: September 22, 2015
Last Updated: February 28, 2019

DOWNLOAD NOW



Calaspoagase Pegol-mknl (Asparlas™)

Original FDA Approval: December 20, 2018
Last Updated: February 4, 2019

DOWNLOAD NOW



Cemiplimab-rwlc (Libtayo®)

Original FDA Approval: September 9, 2018
Last Updated: October 15, 2018

DOWNLOAD NOW



Patisiran (Onpattro™)

Original FDA Approval: August 10, 2018
Last Updated: August 13, 2018

DOWNLOAD NOW



Erenumab-aooe (Aimovig™)

Original FDA Approval: May 17, 2018
Last Updated: March 9, 2018

DOWNLOAD NOW



Sacituzumab Govitecan

Complete Response Letter: January 17, 2019
Last Updated: January 17, 2019

DOWNLOAD NOW

Niraparib (Zejula®)

PDUFA: October 10, 2019
Last Updated: September 19, 2019

DOWNLOAD NOW



Upadacitinib

Original FDA Approval: August 16, 2019
Last Updated: August 19, 2019

DOWNLOAD NOW



Daratumumab (Darzalex®)

Original FDA Approval: November 16, 2015
Last Updated: August 12, 2019

DOWNLOAD NOW



OnabotulinumtoxinA (Botox®)

Original FDA Approval: April 12, 2002
Last Updated: August 2, 2019

DOWNLOAD NOW



Golodirsen

PDUFA: August 19, 2019
Last Updated: July 17, 2019

DOWNLOAD NOW



Celiprolol (Edsivo™)

Complete Reponse Letter: June 25, 2019
Last Updated: June 25, 2019

DOWNLOAD NOW



Galcanezumab-gnlm (Emgality®)

Original FDA Approval: September 27, 2018
Supplemental Approval: June 04, 2019

DOWNLOAD NOW



Onasemnogene abeparvovec-xioi (Zolgensma®)

Original FDA Approval: May 24, 2019
Last Updated: May 24, 2019

DOWNLOAD NOW



Risankizumab-rzaa (Skyrizi™)

Original FDA Approval: April 23, 2019
Last Updated: April 25, 2019

DOWNLOAD NOW



Siponimod (Mayzent®)

Original FDA Approval: March 26, 2019
Last Updated: March 26, 2019

DOWNLOAD NOW



Caplacizumab (Cablivi™)

Original FDA Approval: February 6, 2018
Last Updated: February 20, 2019

DOWNLOAD NOW



Venetoclax (Venclexta ®)

Original FDA Approval: April 11, 2016
Last Updated: January 17, 2019

DOWNLOAD NOW



Fremanezumab-vfrm (Ajovy™)

Original FDA Approval: September 14, 2018
Last Updated: September 24, 2018

DOWNLOAD NOW



Mogamulizumab-kpkc (Poteligeo ®)

Original FDA Approval: August 8, 2018
Last Updated: August 10, 2018

DOWNLOAD NOW



Ibalizumab-uiyk (Trogarzo™)

Original FDA Approval: March 6, 2018
Last updated: March 6, 2018

DOWNLOAD NOW



Darolutamide (Nubeqa®)

Original FDA Approval: July 30, 2019
Last Updated: September 19, 2019

DOWNLOAD NOW



Fedratinib

PDUFA: September 3, 2019
Last Updated: August 2, 2019

DOWNLOAD NOW



AV-001

PDUFA: December 15, 2019
Last Updated: August 12, 2019

DOWNLOAD NOW



Rituximab (Rituxan®) Biosimilars

Original FDA Approval: November 26, 1997
Last Updated: July 23, 2019

DOWNLOAD NOW



Dupilumab (Dupixent®)

Original FDA Approval: March 28, 2017
Last Updated: July 3, 2019

DOWNLOAD NOW



Polatuzumab vedotin-piiq (Polivy™)

Original FDA Approval: June 10, 2019
Last Updated: June 11, 2019

DOWNLOAD NOW



Avelumab (Bavencio®)

Original FDA Approval: March 23, 2017
Last Updated: May 30, 2019

DOWNLOAD NOW



Ivosidenib (Tibsovo®)

Original FDA Approval: August 21, 2018
Last Updated: May 16, 2019

DOWNLOAD NOW



Quizartinib

PDUFA: August 25, 2019
Last Updated: April 17, 2019

DOWNLOAD NOW



Atezolizumab (Tecentriq®)

Original FDA Approval: May 18, 2016
Last Updated: March 20, 2019

DOWNLOAD NOW



Nivolumab + Ipilimumab (Opdivo® + Yervoy®)

Original FDA Approval: September 30, 2015
Last Updated: February 11, 2019

DOWNLOAD NOW



Pegfilgrastim-cbqv (Udenyca™)

Original FDA Approval: November 2, 2018
Last Updated: November 5, 2018

DOWNLOAD NOW



Moxetumomab pasudotox (Lumoxiti™)

Original FDA Approval: September 13, 2018
Last Updated: September 21, 2018

DOWNLOAD NOW



Volanesorsen (Waylivra)

Complete Response Letter: August 27, 2018
Last Updated: July 25, 2018

DOWNLOAD NOW



Tildrakizumab-asmn (Ilumya™)

Original FDA Approval: March 20, 2018
Last Updated: February 28, 2018

DOWNLOAD NOW



Pembrolizumab (Keytruda®)

Original FDA Approval: September 4, 2014
Last Updated: September 19, 2019

DOWNLOAD NOW



Entrectinib (Rozlytrek)

Original FDA Approval: August 15, 2019
Last Updated: August 19, 2019

DOWNLOAD NOW



Pexidartinib hydrochloride

Original FDA Approval: August 2, 2019
PDUFA: August 3, 2019

DOWNLOAD NOW



Apremilast (Otezla®)

Original FDA Approval: March 21, 2014
Last Updated: July 23, 2019

DOWNLOAD NOW



Eculizumab (Soliris®)

Original FDA Approval: March 16, 2007
Last Updated: June 28, 2019

DOWNLOAD NOW



Selinexor (Xpovio™)

Original FDA Approval: July 3, 2019
Last Updated: June 11, 2019

DOWNLOAD NOW



Lenalidomide (Revlimid®)

Original FDA Approval: December 27, 2005
Last Updated: May 28, 2019

DOWNLOAD NOW



Aflibercept (Eylea®)

Original FDA Approval: November 18, 2011
Last Updated: May 16, 2019

DOWNLOAD NOW



Immune Globulin Intravenous, Human (ASCENIV™)

Original FDA Approval: April 1, 2019
Last Updated: April 12, 2019

DOWNLOAD NOW



Olaparib (Lynparza®)

Original FDA Approval: December 12, 2014
Last Updated: February 29, 2019

DOWNLOAD NOW



Tagraxofusp-erzs (Elzonris™)

Original FDA Approval: December 21, 2018
Last Updated: February 4, 2019

DOWNLOAD NOW



Inotersen sodium (Tegsedi™)

Original FDA Approval: October 5, 2018
Last Updated: October 16, 2018

DOWNLOAD NOW



Lanadelumab-flyo (Takhzyro™)

Original FDA Approval: August 23, 2018
Last Updated: August 27, 2018

DOWNLOAD NOW



Burosumab-twza (Crysvita®)

Original FDA Approval: April 17, 2018
Last Updated: March 14, 2018

DOWNLOAD NOW



Trastuzumab (Herceptin®) Biosimilars

Original FDA Approval: September 25, 1998
Last Updated: February 26, 2018

DOWNLOAD NOW



Did you find what you need?

Please enter your information if you’d like to learn more: